Demonstrates candidate prioritization of TCM small molecules in gastric cancer, indicating effective therapeutic options.
Traditional Chinese Medicine (TCM) represents a multi-component therapeutic system with substantial chemical complexity. This complexity makes it difficult to directly elucidate anti-gastric cancer mechanisms from macroscopic herbal formulae. To support the systematic prioritization of potential small-molecule candidates, this study focuses on screening bioactive small-molecule constituents from TCM. We constructed a heterogeneous network integrating Chinese herbal pieces (CHPs), Chinese patent medicines (CPMs), genes, diseases, and small molecules, and incorporated metapath2vec representations and attention mechanisms into a graph neural network framework, the model is designed to learn relational patterns among heterogeneous nodes. Network pharmacology and in vitro validation in AGS and MKN-45 gastric cancer cell lines show that Icaritin and Arundine inhibit cell proliferation and induce apoptosis. This study presents an AI-assisted pipeline for candidate prioritization, providing methodological support for the systematic prioritization and preliminary validation of bioactive TCM molecules in gastric cancer.
No takes yet. Share an insight, caveat, or question.
Sheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: